CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

Clinical trial NCT06557096 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06557096
Sponsor: Second Affiliated Hospital of Nanchang University
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Circulating Tumor Cell EGF-R Positive Non-Small Cell Lung Cancer

Start date: 2024-08-20
Primary completion: 2027-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.